Quaker Chemical (KWR) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
31 Jul, 2026Executive summary
Net sales for Q2 2026 reached $533 million, up 10% year-over-year, driven by 7% volume growth, favorable currency, and pricing, with all segments contributing and Asia-Pacific leading growth.
Adjusted EBITDA hit a record $85.2 million (16.0% margin), up 13% year-over-year, marking the fourth consecutive quarter of profitability growth.
Non-GAAP diluted EPS was $2.19, up 28% year-over-year; GAAP diluted EPS was $1.55, with net income of $26.8 million, reversing a prior-year loss.
Successfully navigated raw material cost inflation and supply disruptions from geopolitical conflicts, maintaining supply continuity and implementing price increases.
Launched a new manufacturing facility in China, enhancing local production capabilities and operational flexibility in Asia-Pacific.
Financial highlights
Gross profit for Q2 2026 was $189.2 million (35.5% margin), up 10% year-over-year, though margin declined slightly due to higher raw material costs.
Operating income was $40.6 million, compared to a loss of $52.5 million in Q2 2025; operating margin improved to 7.6%.
Adjusted EBITDA margin improved to 16.0% from 15.6% year-over-year.
Cash from operations was $29 million in Q2 and $33 million year-to-date, down from last year due to higher working capital needs.
SG&A expenses rose 11% to $140.5 million, mainly from higher incentive compensation and transformation costs.
Outlook and guidance
End markets are expected to remain flat to modestly positive in the second half of 2026, with stable demand trends for Q3.
Gross margin percentage anticipated to remain in Q2 range for Q3, with a target to exceed 36% by year-end as pricing actions take effect.
Project mid to high single-digit adjusted EBITDA growth for full year 2026, supported by share gains and cost management.
The 2026 global business transformation program is expected to generate $20–30 million in annualized cost savings by 2028.
Management expects to maintain sufficient liquidity and remain in compliance with credit facility terms.
Latest events from Quaker Chemical
- Directors elected, auditor ratified, Chair retires, and CEO's growth strategy highlighted.KWR
AGM 2026 - Q1 2026 delivered 8% sales growth, higher earnings, and strong Asia/Pacific performance.KWR
Q1 2026 - Virtual annual meeting to vote on directors, executive pay, auditor, and review ESG progress.KWR
Proxy filing - Q4 2025 delivered higher sales and EBITDA, led by Asia-Pacific growth and acquisitions.KWR
Q4 2025 - Net income and margins rose in Q2 2024 despite lower sales, with further growth expected.KWR
Q2 2024 - Q3 2024 sales fell 6% as Americas and EMEA softened, but Asia/Pacific grew and margins held firm.KWR
Q3 2024 - Growth, margin recovery, and targeted M&A drive resilience in a fragmented global market.KWR
Gabelli Funds' 16th Annual Specialty Chemicals Symposium - Q1 2025 sales and earnings declined, but liquidity and acquisitions support a stable outlook.KWR
Q1 2025 - Q4 2024 saw lower sales and earnings, but cash flow and acquisitions support 2025 growth.KWR
Q4 2024